HiSiaddi is an innovative foreign trade service provider driven by technological transformation and cross-border trade. We operate under a comprehensive service framework defined as "1+2+3+4=1" and can supply alpha-arbutin sourced directly from well-known original manufacturers. As a foreign trade enterprise with independent R&D capabilities, HiSiaddi has repeatedly resolved customized alpha-arbutin procurement demands for clients through technological cooperation with manufacturers and precise market insight. Below is a detailed case of our customized alpha-arbutin solution.
For more customized service inquiries, please contact HiSiaddi customer service.
Purchaser: Lumina Dermo, a high-end clinical skincare group based in Milan, Italy. The group operates private dermatology clinics and premium medical aesthetic centers across Southern Europe, specializing in post-procedure brightening serums, barrier-repair lightening essences, and customized clinic whitening kits. All products comply with EU Regulation EC1223, SCCS raw material safety standards, and COSMOS natural organic certification. Previously, the group sourced high-purity customized alpha-arbutin (CAS: 84380-01-8) exclusively from Sumitomo Chemical, Japan, with an annual stable procurement volume of 52 tons.
In 2025, the client launched a domestic raw material localization replacement initiative and required fully customized non-standard alpha-arbutin, rejecting standard 99% national standard stock materials available on the market. The client reached out to three leading domestic synthetic biology manufacturers (Garden Biochemical, Shandong Tianli, Jiangsu Hanshitong), yet all manufacturers operated standardized continuous mass production lines and only offered their fixed standard grades. They refused to adjust production processes, internal control indicators, powder morphology, and compliance documentation to align with the client’s formulas and updated EU regulations. All three manufacturers stated that independent technical renovation for customization would incur excessive costs and small-batch trial production would be unprofitable. This stalled the launch of the client’s new organic spot-fading serum.
The group entrusted HiSiaddi with full-process management covering customized process development, indicator calibration, phased sample production, and complete compliance support. The target raw material was defined as high-purity medical customized grade, distinct from generic cosmetic-grade alpha-arbutin sold in the market.
1. Customized Purity: HPLC purity ≥99.65%, β-arbutin isomer impurity ≤0.08%, free hydroquinone ≤0.2ppm (mandatory limit under updated EU regulations). This eliminates risks of EU customs inspection penalties for alpha-arbutin and accommodates high-concentration 2% formulations for clinical serums.
2. Customized Crystal Powder Form: Customized 90-mesh quasi-spherical crystals with a repose angle of 34°±2°, low moisture absorption, compatible with the client’s fully automated low-temperature closed feeding production lines to avoid agglomeration and pipeline blockages.
3. Customized Internal Physical & Chemical Controls: 1% aqueous solution pH stabilized at 5.9~6.1, melting range 204~205°C, batch-to-batch pH fluctuation ≤±0.1. Prevents hydrolysis, breakdown, and hydroquinone precipitation when co-formulated with L-Ascorbic Acid and Niacinamide.
4. Customized Solvent Residue Limits: Single residual organic solvents including methanol, ethanol, ethyl acetate <5ppm, meeting COSMOS organic raw material audit requirements.
5. Optional Customized Liquid Formulation: 15% sterile aqueous alpha-arbutin solution without preservatives, exclusively for the client’s single-dose ampoule essence production lines.
Domestic leading manufacturers use fixed enzymatic catalysis parameters and rapid cooling crystallization for mass production, yielding predominantly 120-mesh fine powder with β-isomer levels generally above 0.3%. Optimizing purification and slow crystallization requires halting production lines to renovate refining workshops. Prioritizing profits from standard stock orders, manufacturers declined to fine-tune production line parameters solely for this high-end overseas client and only offered generic national standard-grade materials.
The EU tightened alpha-arbutin control standards in 2025: maximum allowable concentration is 2% for leave-on face creams and 0.5% for body lotions. Raw materials with excess hydroquinone result in finished products being blocked at EU customs and prohibited from market launch. Generic domestic stock materials contain 0.8~1.5ppm free hydroquinone, exceeding the client’s customized limit.
The client’s ampoule essence line requires pre-dissolved sterile 15% alpha-arbutin solution. Most domestic manufacturers only produce solid crystalline powder, lacking Grade 10,000 sterile filling workshops and mature liquid customization processes.
Manufacturers’ standard Certificates of Analysis (CoA) are issued in Chinese and aligned with domestic national standards. No full-item English test reports or SDS documents compiled per EU standards are provided, preventing the client from completing EU cosmetic notification under CPNP.
HiSiaddi conducted horizontal technical route comparisons across the three leading manufacturers:
1. Garden Biochemical: Strong bulk mass production capacity but limited flexible pilot production lines with high renovation costs; prioritized standard stock production → Eliminated.
2. Shandong Tianli: Mature mass production of cosmetic-grade materials, insufficient high-purity refining equipment to control trace isomers → Eliminated.
3. Selected Jiangsu Hanshitong Pharmaceutical: In-house flexible pilot lines for enzymatic catalysis synthesis and Grade 10,000 sterile liquid formulation workshops, enabling flexible adjustment of synthesis and recrystallization parameters.
HiSiaddi leveraged the 52-ton annual long-term order as bargaining leverage to sign a dedicated customization agreement, stipulating three implementation phases: 5kg lab trial → 50kg pilot scale-up → formal mass production. The manufacturer shared partial technical debugging costs to eliminate concerns over losses from production line adjustments.
1. Optimized enzymatic catalysis synthesis: Modified glycosidase catalytic systems to selectively boost α-configuration yield and reduce β-arbutin byproduct generation. Added two-stage molecular membrane impurity removal and low-temperature gradient recrystallization to eliminate free hydroquinone. After three rounds of trials, HPLC purity reached 99.68%, β-isomer 0.06%, hydroquinone 0.15ppm — all within specified limits.
2. Regulated cooling rates and stirring speeds during crystallization, abandoning rapid quenching to produce 90-mesh spherical crystals with a measured repose angle of 33.7°. Optimized drying processes to lower moisture absorption.
3. Added a terminal pH buffering stage to lock 1% aqueous solution pH at approximately 5.95, with strict controls on drying loss and solvent residues.
Samples were air-freighted to Italy for client lab testing: 2% alpha-arbutin co-formulated with 10% L-Ascorbic Acid showed no hydrolysis, precipitation, or hydroquinone rebound after 90 days of accelerated storage at 45°C.
HiSiaddi deployed on-site supervisors to monitor full production lines and formalize standardized operating procedures (SOPs) for synthesis, purification, and crystallization, fixing all feed ratios and temperature control parameters. Pilot finished products underwent dual authoritative testing by a domestic CNAS-accredited laboratory and SGS Italy, fully complying with customized internal controls and EU regulations. Custom double-layer light-proof vacuum aluminum foil packaging with desiccants was developed to prevent moisture degradation during transoceanic shipping.
Utilizing the manufacturer’s Grade 10,000 sterile workshop, solid customized alpha-arbutin was dissolved in low-temperature sterile purified water, followed by terminal sterile ultrafiltration without any preservatives to precisely prepare 15% aqueous solution. Finished liquid was sealed in 5kg sterile drums for direct feeding into the client’s automated ampoule filling lines.
1. Rewrote full English GHS-MSDS documents aligned with EU CLP and REACH regulations, paired with SCCS-recognized raw material safety assessment reports.
2. Issued bilingual Chinese-English CoAs listing CAS numbers, separate impurity data, and production traceability codes matching customized specifications.
3. Assisted manufacturers in coordinating EU certification bodies to supplement COSMOS pre-audit materials, enabling the client to complete CPNP raw material notifications and pass Italian drug administration customs reviews.
The 52-ton annual order was split into two product categories: 42 tons of solid customized crystals (primary for spot-fading serums) and 10 tons of 15% sterile liquid (ampoule-specific), shipped in seven batches from Shanghai Port to Genoa, Italy.
1. Client Benefits: Customized alpha-arbutin cleared customs without inspections. The client’s new organic clinical spot-fading serum and single-dose ampoule essences successfully completed EU registration and launched across over 280 private dermatology clinics throughout Italy. Comprehensive raw material procurement costs dropped by 30% compared to Japanese imports. A renewed 58-ton annual framework order was signed the following year, alongside joint R&D for deoxyarbutin derivatives.
2. Manufacturer Benefits: This high-end Italian customization project enabled the factory to finalize standardized flexible production lines for high-purity customized alpha-arbutin and mature liquid sterile mass production processes. Subsequent customized orders were secured from three European clinical skincare brands in Spain and Portugal, delivering a 29% export premium for high-end customized grades.
3. HiSiaddi Foreign Trade Benefits: Standardized service model for alpha-arbutin was established covering "spec customization → technical renovation → dual solid/liquid formulation development → EU compliance support". The business scope was expanded to high-end customized foreign trade of other brightening raw materials including Niacinamide and Tranexamic Acid.
Most domestic alpha-arbutin manufacturers prioritize cost reduction via standardized mass production, operating inflexible production lines and declining non-standard refined customization to focus on stock grade sales. Mid-to-high-end European medical aesthetic skincare brands are constrained by strict EU regulations and high-concentration formulations, making generic stock raw materials unsuitable for market launch. Leveraging full industrial chain resources, HiSiaddi secured manufacturer willingness to conduct technical renovations via long-term orders, resolving all client customization pain points through process optimization, dual-formulation development, and compliance documentation. This broke down supply chain barriers preventing domestic high-end brightening raw materials from entering mid-to-high-end Southern European skincare markets.
For more customized service inquiries, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
